HROW
HARROW, INC.
Key Financials
Operating Income
$30.5M
↑ 245.9%
Gross Profit
$204.4M
↑ 35.9%
Net Income
$-5139000
↑ 70.6%
Total Assets
$399.5M
↑ 2.7%
EPS (Diluted)
$-0.14
↑ 71.4%
Total Liabilities
$347.4M
↑ 8.7%
Revenue
$272.3M
↑ 36.4%
Shareholders' Equity
$52.4M
↓ 24.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 3/27/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 8-K | 3/24/2026 | View on SEC |
| 8-K | 3/24/2026 | View on SEC |
| SCHEDULE 13G | 3/11/2026 | View on SEC |
| 8-K | 3/10/2026 | View on SEC |
| 4 | 3/5/2026 | View on SEC |
| 4 | 3/3/2026 | View on SEC |
| 10-K | 3/2/2026 | View on SEC |
| 8-K | 3/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HROW |
| Company Name | HARROW, INC. |
| CIK | 1360214 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 615.733.4731 |